03/31/2021: Lab Advisory: FDA Publishes New Web Page on Impact of SARS-CoV-2 Viral Mutations on COVID-19 Molecular Tests

CDC's Laboratory Outreach Communication System (LOCS)

Audience: Individuals Performing COVID-19 Testing

Level: Laboratory Advisory

On March 30, 2021, the U.S. Food and Drug Administration (FDA) posted a new Web pageexternal icon for clinical laboratory staff and health care providers about the impact of viral mutations on COVID-19 molecular tests. The FDA will update this page as significant new information becomes available.

The Web page includes:

  • Background and considerations for SARS-CoV-2 viral mutations
  • General information for clinical laboratory staff and health care providers
  • Specific molecular tests impacted by viral mutations and recommendations for those tests

Please share this message with your networks and invite them to opt in to LOCS to receive future updates.

Online resources:

If you have any questions, please contact us at LOCS@cdc.gov.

Thank you,

Laboratory Outreach Communication System | Division of Laboratory Systems (DLS)

Center for Surveillance, Epidemiology, and Laboratory Services (CSELS)

Centers for Disease Control and Prevention (CDC)

LOCS@cdc.gov

www.cdc.gov/csels/dls/locs

Page last reviewed: March 31, 2021